Libya vs Papua New Guinea: Access to anti-retroviral drugs, male
Libya
49.0%
in 2023
Papua New Guinea
50.0%
in 2024
Libya rank
119th
Papua New Guinea rank
117th
Access to anti-retroviral drugs, male over time
- Libya
- Papua New Guinea
How they compare
Papua New Guinea currently reports 50.0% against 49.0% in Libya, a difference of 1.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 119th and Papua New Guinea ranks 117th of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.0% | 4.0% | 25.0% | Libya |
| 2010s | 63.9% | 28.3% | 35.6% | Libya |
| 2020s | 47.8% | 43.8% | 4.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Libya or Papua New Guinea?
- Papua New Guinea, at 50.0% against 49.0% in Libya as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Libya and Papua New Guinea?
- 1.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Libya and Papua New Guinea?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Papua New Guinea rank globally for access to anti-retroviral drugs, male?
- Libya ranks 119th and Papua New Guinea ranks 117th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.